A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Ovarian Neoplasms|Breast Neoplasms|Paresthesia
Sponsor: Merck Sharp & Dohme LLC